World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
48203
World Ranking
8447
National Ranking
4367

Overview

Michael Charlton is affiliated with the University of Chicago in the United States. Their research primarily focuses on medicine, with a significant body of work in epidemiology, hepatology, surgery, endocrinology, diabetes and metabolism, and infectious diseases.

Their publications span a broad range of topics related to liver diseases and metabolic conditions. The main topics of their research include:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • Organ Transplantation Techniques and Outcomes
  • Liver Diseases and Immunity
  • Pancreatitis Pathology and Treatment
  • Hepatitis C virus research

Michael Charlton has contributed to a variety of scientific articles published in notable journals and venues. Some of the recent papers involving topics in liver disease and related fields are:

  • A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis (2024) published in New England Journal of Medicine
  • Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation (2020) published in Hepatology
  • Liver Transplantation 2023: Status Report, Current and Future Challenges (2023) published in Clinical Gastroenterology and Hepatology
  • Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance (2023) published in Journal of Hepatology
  • Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD (2022) published in Journal of Hepatology

The scientist frequently publishes in several leading journals, with the highest number of publications appearing in:

  • Journal of Hepatology (26 publications)
  • Gastroenterology (6 publications)
  • Transplantation (4 publications)
  • Clinical Gastroenterology and Hepatology (3 publications)
  • Liver Transplantation (3 publications)

Collaboration is a notable aspect of Michael Charlton's work, often co-authoring with researchers active in hepatology and related areas. Frequent co-authors include:

  • Naim Alkhouri (26 joint publications)
  • Mazen Noureddin (25 joint publications)
  • Jörn M. Schattenberg (21 joint publications)
  • Julie Dubourg (18 joint publications)
  • Thomas G. Cotter (16 joint publications)

The volume and diversity of Michael Charlton's research indicate extensive involvement in clinical and scientific inquiries related to liver diseases, metabolism, transplantation, and immunological factors affecting hepatic health.

Best Publications

  • The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Michael Charlton

  • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

    Michael R. Charlton;Justin M. Burns;Rachel A. Pedersen;Kymberly D. Watt

  • Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis

    M. P. Curry;J. G. O'Leary;N. Bzowej;A. J. Muir

  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    Michael Charlton;Gregory T. Everson;Steven L. Flamm;Princy Kumar

  • Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

    Kymberly Ds Watt;Rachel A Pedersen;Walter K Kremers;Julie K Heimbach

  • Association of Non-Alcoholic Fatty Liver Disease With Chronic Kidney Disease: A Systematic Review and Meta-Analysis

    Giovanni Musso;Roberto Gambino;James H. Tabibian;Mattias Ekstedt

  • Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation

    David Goldberg;David Goldberg;Ivo C. Ditah;Kia Saeian;Mona Lalehzari

  • Predictors of patient and graft survival following liver transplantation for hepatitis C

    Michael Charlton;Eric Seaberg;Russell Wiesner;James Everhart

  • A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice.

    M.H. Khadra;R.S. Pickard;M. Charlton;P.H. Powell

  • The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

    Rohit Loomba;Eric Lawitz;Parvez S. Mantry;Saumya Jayakumar

  • Nonalcoholic fatty liver disease: a review of current understanding and future impact.

    Michael Charlton

  • Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.

    Petra Hirsova;Samar H. Ibrahim;Anuradha Krishnan;Vikas K. Verma

  • Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis

    I. W. Graziadei;R. H. Wiesner;P. J. Marotta;M. K. Porayko

  • Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition

    Michael Charlton;Anuradha Krishnan;Kimberly Viker;Schuyler Sanderson

  • Recurrence of primary sclerosing cholangitis following liver transplantation

    Ivo W. Graziadei;Russell H. Wiesner;Kenneth P. Batts;Paul J. Marotta

  • Apolipoprotein synthesis in nonalcoholic steatohepatitis

    Michael Charlton;Raghavakaimal Sreekumar;Deborah Rasmussen;Keith Lindor

  • Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    Zobair M. Younossi;Rohit Loomba;Quentin M. Anstee;Mary Eugenia Rinella

  • Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

    Michael Charlton;Edward Gane;Michael P. Manns;Robert S. Brown

Frequent Co-Authors

Rohit Loomba
Rohit Loomba University of California, San Diego
Nezam H. Afdhal
Nezam H. Afdhal Beth Israel Deaconess Medical Center
John G. McHutchison
John G. McHutchison Duke University
Gregory J. Gores
Gregory J. Gores Mayo Clinic
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital
Stephen H. Caldwell
Stephen H. Caldwell University of Virginia
Zobair M. Younossi
Zobair M. Younossi Inova Health System
Anna Mae Diehl
Anna Mae Diehl Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing to study medicine in the USA can open doors to a range of related online degree programs and healthcare career pathways. For those interested in the business side of healthcare, pursuing financial aid for medical billing and coding can make entry into this high-demand field more affordable.

Nursing remains one of the most rewarding and flexible healthcare careers. Many aspiring nurses are now seeking nursing school that does not require teas test, making it easier to meet admission requirements and begin training quickly.

If your interests are in administration and leadership, an online health care administration degree can fast-track your journey to management roles in hospitals and health organizations.

For nurses with an ADN qualification, exploring adn to fnp bridge programs offers a flexible route to becoming a Family Nurse Practitioner, expanding career options and earning potential.

Best Scientists Citing Michael Charlton

Trending Scientists

Recently Published Articles